Evaluation of limited-sampling strategies to calculate AUC(0–24) and the role of CYP3A5 in Chilean pediatric kidney recipients using extended-release tacrolimus
Background: Kidney transplantation (KTx) requires immunosuppressive drugs such as Tacrolimus (TAC) which is mainly metabolized by CYP3A5. TAC is routinely monitored by trough levels (C0) although it has not shown to be a reliable marker. The area-under-curve (AUC) is a more realistic measure of drug...
Main Authors: | Carla Galvez, Pía Boza, Mariluz González, Catalina Hormazabal, Marlene Encina, Manuel Azócar, Luis E. Castañeda, Angélica Rojo, María Luisa Ceballos, Paola Krall |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1044050/full |
Similar Items
-
Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation
by: Jefferson Antonio Buendía, et al.
Published: (2020-09-01) -
Induction of CYP3A activity by dexamethasone may not be strong, even at high doses: insights from a case of tacrolimus co-administration
by: Yoshiyuki Ohno, et al.
Published: (2023-12-01) -
CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
by: Chen L, et al.
Published: (2018-03-01) -
Pharmacogenomic Analysis of CYP3A5*3 and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes
by: Nguyen TVA, et al.
Published: (2024-02-01) -
Analyses of AUC<sub>(0–12)</sub> and C<sub>0</sub> Compliances within Therapeutic Ranges in Kidney Recipients Receiving Cyclosporine or Tacrolimus
by: Aurelija Radzevičienė, et al.
Published: (2020-12-01)